Biomarker Discovery in Parkinson’s Disease: Present Challenges and Future Opportunities
Sign Up to like & getrecommendations! Published in 2017 at "Neuroscience Bulletin"
DOI: 10.1007/s12264-017-0184-4
Abstract: Parkinson’s disease (PD) is the second most common neurodegenerative disorder affecting more than 1% of the older population. Histopathologically, PD is characterized by a severe loss of dopaminergic neurons in the substantia nigra and cytoplasmic… read more here.
Keywords: biomarker discovery; disease present; diagnosis; discovery parkinson ... See more keywords
Intracranial Metastatic Disease: Present Challenges, Future Opportunities
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.855182
Abstract: Intracranial metastatic disease (IMD) is a prevalent complication of cancer that significantly limits patient survival and quality of life. Over the past half-century, our understanding of the epidemiology and pathogenesis of IMD has improved and… read more here.
Keywords: disease present; challenges future; present challenges; intracranial metastatic ... See more keywords
Sleep Disorders in Parkinson's Disease: Present Status and Future Prospects
Sign Up to like & getrecommendations! Published in 2018 at "Chinese Medical Journal"
DOI: 10.4103/0366-6999.229903
Abstract: Epidemiological studies have demonstrated that sleep disorders are associated with a decline in cognitive performance, productivity, mood, and quality of life, as well as with major social, medical, and economic impacts. At present, the pathophysiology… read more here.
Keywords: sleep disorders; disease present; status future; present status ... See more keywords